马应龙(600993.SH)：子公司获得药品注册证书

Group 1 - The company, Mayinglong Pharmaceutical (600993.SH), announced that its subsidiary, Jiangxi Mayinglong Meikang Pharmaceutical Co., Ltd., has received the drug registration certificate for Olopatadine Hydrochloride Eye Drops from the National Medical Products Administration [1] - The approved drug is indicated for the treatment of allergic conjunctivitis-related eye itching [1]